Literature DB >> 6263179

Activity of mecillinam alone and in combination with other beta-lactam antibiotics.

R J Fass.   

Abstract

The in vitro activities of mecillinam, ticarcillin, cefamandole, and cefoxitin, singly and in all possible combinations, against 53 clinical isolates were studied by a checkerboard method of determining minimal inhibitory concentrations. For selected representative strains, bactericidal activity was determined by minimal bactericidal concentrations and killing curves. Mecillinam was the least active antibiotic against gram-positive cocci, Pseudomonas aeruginosa, and Bacteroides fragilis and the most active against Enterobacteriaceae. Reproducibility of mecillinam minimal inhibitory concentrations for susceptible Enterobacteriaceae was often poor, however, due to minor variations in inoculum size. When mecillinam resistance was observed with Enterobacteriaceae, partial inhibition could be demonstrated at concentrations below minimal inhibitory concentrations, and bacterial cells were consistently ovoid or round; under those conditions the addition of a second study antibiotic resulted in marked synergistic inhibition and killing which was independent of inoculum size and susceptibility to the second antibiotic. In contrast, synergy with mecillinam against mecillinam-susceptible strains or with other antibiotic combinations against any species was not consistently observed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6263179      PMCID: PMC352987          DOI: 10.1128/AAC.18.6.906

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Mecillinam (FL 1060), a 6beta-amidinopenicillanic acid derivative: in vitro evaluation.

Authors:  L Tybring
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

2.  Mecillinam, a novel penicillanic acid derivative with unusual activity against gram-negative bacteria.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

3.  FL-1060: a new penicillin with a unique mode of action.

Authors:  J T Park; L Burman
Journal:  Biochem Biophys Res Commun       Date:  1973-04-16       Impact factor: 3.575

4.  6 -amidinopenicillanic acids--a new group of antibiotics.

Authors:  F Lund; L Tybring
Journal:  Nat New Biol       Date:  1972-04-05

5.  Distinct penicillin binding proteins involved in the division, elongation, and shape of Escherichia coli K12.

Authors:  B G Spratt
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

6.  In vivo synergy between 6 beta-amidinopenicillanic acid derivatives and other antibiotics.

Authors:  E Grunberg; R Cleeland; G Beskid; W F DeLorenzo
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

7.  Mecillinam (FL 1060), a 6beta-amidinopenicillanic acid derivative: bactericidal action and synergy in vitro.

Authors:  L Tybring; N H Melchior
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

8.  Activity of semisynthetic penicillins and synergism with mecillinam against Bacteroides species.

Authors:  I Trestman; D Kaye; M E Levison
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

9.  Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases.

Authors:  C C Sanders; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1979-06       Impact factor: 5.191

10.  Synergy of mecillinam, a beta-amidinopenicillanic acid derivative, combined with beta-lactam antibiotics.

Authors:  J C Neu
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

View more
  6 in total

1.  The Novel β-Lactam Enhancer Zidebactam Augments the In Vivo Pharmacodynamic Activity of Cefepime in a Neutropenic Mouse Lung Acinetobacter baumannii Infection Model.

Authors:  S S Bhagwat; H Periasamy; S S Takalkar; S R Palwe; H N Khande; M V Patel
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

2.  Comparative in vitro activities of azlocillin-cefotaxime and azlocillin-tobramycin combinations against blood and multi-drug resistant bacterial isolates.

Authors:  R J Fass
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

3.  Comparative in vitro antibacterial activity of seven semi-synthetic penicillins against aerobic gram-negative bacteria and enterococci.

Authors:  A Thabaut; J L Durosoir; P Saliou
Journal:  Infection       Date:  1982       Impact factor: 3.553

4.  In vitro activity of moxalactam and mecillinam, singly and in combination, against multi-drug-resistant Enterobacteriaceae and Pseudomonas species.

Authors:  R J Fass
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

5.  Multiple-dose pharmacokinetics of amdinocillin in healthy volunteers.

Authors:  S L Barriere; J G Gambertoglio; E T Lin; J E Conte
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

6.  Interactions of OP0595, a Novel Triple-Action Diazabicyclooctane, with β-Lactams against OP0595-Resistant Enterobacteriaceae Mutants.

Authors:  David M Livermore; Marina Warner; Shazad Mushtaq; Neil Woodford
Journal:  Antimicrob Agents Chemother       Date:  2015-11-09       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.